Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 21:39:56 - browse：158

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： After sickle

hotspot

WSS

Leqembi, other new Alzheimer’s drugs require better biomarkers

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

The woman behind the Dana Farber

SCOTUS to consider access to abortion pill mifepristone

Pharma patents targeted by Biden in move to slash drug prices

Palantir health business leans on meeting customers’ needs

focus

Wikipedia

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Leukemia patients are helped by Syndax's new type of therapy

Walensky prepares to leave CDC — and Congress — behind

A new study sees potential in DNA sequencing of infants

The high cost of giving birth even with insurance

How the political right came to back psychedelics to treat trauma

Anesthesiologist group: stop taking Ozempic before surgery

New research casts further doubt on a common procedure used with IVF

Affirmative action in medical school literally saved lives

FDA approves world's first CRISPR

entertainment

Oak trusses raised to roof of fire

The woman behind the Dana Farber

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Americans' trust in science, scientist continues decline: Report

Biden launches a new push to limit health care costs

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

entertainment

hotspot

focus

knowledge